Literature DB >> 9324236

Apolipoprotein E gene polymorphism in early and late onset bipolar patients.

F Bellivier1, J L Laplanche, F Schürhoff, J Feingold, A Féline, R Jouvent, J M Launay, M Leboyer.   

Abstract

To explore the involvement of apolipoprotein E gene (APO E) in major depression, we studied the APO E gene polymorphism in a sample of 156 unrelated bipolar patients and 91 healthy volunteers. This population was stratified for age at onset of the affective disorder (onset before 18 years, after 45 years and between 18 and 45 years). Early onset bipolar patients with psychotic symptoms exhibited a significant increase of epsilon4 allele frequency (28.9%) compared to either other bipolar patients (13.1%, chi2 = 6.52, df = 1, P < 0.02) or controls (12.1%, chi2 = 7.01, df = 1, P < 0.01). The association between epsilon4 and early onset bipolar disorder (BPD) with psychotic symptoms suggests that APO E gene is a risk factor for a subgroup of BPD, or influences the phenotypic expression (i.e. psychotic symptoms or age at onset) of manic depressive illness.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9324236     DOI: 10.1016/s0304-3940(97)00624-1

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

Review 1.  Pharmacogenomics and therapeutic prospects in dementia.

Authors:  Ramón Cacabelos
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-03       Impact factor: 5.270

Review 2.  Indices of metabolic dysfunction and oxidative stress.

Authors:  Gemma Casadesus; Paula I Moreira; Akihiko Nunomura; Sandra L Siedlak; William Bligh-Glover; Elizabeth Balraj; Grace Petot; Mark A Smith; George Perry
Journal:  Neurochem Res       Date:  2007-03-07       Impact factor: 3.996

Review 3.  White matter hyperintensities: from medical comorbidities to bipolar disorders and back.

Authors:  Eva Gunde; Ryan Blagdon; Tomas Hajek
Journal:  Ann Med       Date:  2011-07-13       Impact factor: 4.709

4.  ApoE and cholesterol in schizophrenia and bipolar disorder: comparison of grey and white matter and relation with APOE genotype.

Authors:  Fidel Vila-Rodriguez; William G Honer; Sheila M Innis; Cheryl L Wellington; Clare L Beasley
Journal:  J Psychiatry Neurosci       Date:  2011-01       Impact factor: 6.186

5.  Genome-wide scan for genes involved in bipolar affective disorder in 70 European families ascertained through a bipolar type I early-onset proband: supportive evidence for linkage at 3p14.

Authors:  B Etain; F Mathieu; M Rietschel; W Maier; M Albus; P McKeon; S Roche; C Kealey; D Blackwood; W Muir; F Bellivier; C Henry; C Dina; S Gallina; H Gurling; A Malafosse; M Preisig; F Ferrero; S Cichon; J Schumacher; S Ohlraun; M Borrmann-Hassenbach; P Propping; R Abou Jamra; T G Schulze; A Marusic; Z M Dernovsek; B Giros; T Bourgeron; A Lemainque; D Bacq; C Betard; C Charon; M M Nöthen; M Lathrop; M Leboyer
Journal:  Mol Psychiatry       Date:  2006-03-14       Impact factor: 15.992

Review 6.  Pharmacogenetic basis for therapeutic optimization in Alzheimer's disease.

Authors:  Ramón Cacabelos
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

7.  Association of brain-derived neurotrophic factor (BDNF) Val66Met polymorphism with early-onset bipolar disorder.

Authors:  Malik Nassan; Paul E Croarkin; Joan L Luby; Marin Veldic; Paramjit T Joshi; Susan L McElroy; Robert M Post; John T Walkup; Kelly Cercy; Jennifer R Geske; Karen D Wagner; Alfredo B Cuellar-Barboza; Leah Casuto; Catharina Lavebratt; Martin Schalling; Peter S Jensen; Joanna M Biernacka; Mark A Frye
Journal:  Bipolar Disord       Date:  2015-09       Impact factor: 6.744

8.  Development of a Melting Curve-Based Allele-Specific PCR of Apolipoprotein E (APOE) Genotyping Method for Genomic DNA, Guthrie Blood Spot, and Whole Blood.

Authors:  Chia-Hsiang Chen
Journal:  PLoS One       Date:  2016-04-14       Impact factor: 3.240

9.  Interaction between SLC6A4 promoter variants and childhood trauma on the age at onset of bipolar disorders.

Authors:  B Etain; M Lajnef; A Henrion; A A Dargél; L Stertz; F Kapczinski; F Mathieu; C Henry; S Gard; J P Kahn; M Leboyer; S Jamain; F Bellivier
Journal:  Sci Rep       Date:  2015-11-06       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.